Detection of Left Atrial Remodeling by Three-Dimensional Echocardiography in Symptomatic Patients Known to Had

Taher Said Abd Elkareem1,2, Shaimaa Habib3, Amr Shehata4

  • 1Department of Cardiology, Nizwa Hospital, Nizwa, Oman.

Cardiology Research
|October 18, 2024
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) patients exhibit impaired left atrial (LA) function and increased LA volume. Three-dimensional echocardiography reveals adverse LA remodeling, highlighting its role in HCM assessment.

Area of Science:

  • Cardiology
  • Inherited cardiovascular diseases
  • Echocardiography

Background:

  • Hypertrophic cardiomyopathy (HCM) is a prevalent inherited heart disorder and a leading cause of sudden cardiac death.
  • Left atrial (LA) dilatation is common in HCM due to impaired left ventricular (LV) relaxation or direct LA myocardial involvement.

Purpose of the Study:

  • To assess left atrial (LA) remodeling and mechanics in patients with non-obstructive hypertrophic cardiomyopathy (HCM).
  • To evaluate the utility of three-dimensional (3D) echocardiography in characterizing LA abnormalities in HCM.

Main Methods:

  • Enrolled 170 patients with non-obstructive HCM and 30 healthy controls.
  • Performed two-dimensional (2D) and three-dimensional (3D) echocardiography to measure LV dimensions, function, LA dimensions, LA deformations, pulmonary artery pressure (PAP), and LV global longitudinal strain (LVGLS).
  • Utilized 3D speckle tracking echocardiography (STE) for detailed LA volume and mechanics assessment.

Main Results:

  • Patients with HCM showed significantly reduced LA reservoir, conduit, and booster pump functions compared to controls (P < 0.001).
  • HCM patients had higher pulmonary artery pressure (PAP) and lower LV global longitudinal strain (LVGLS).
  • 3D STE revealed significantly increased indexed maximum LA volume (Vmax indexed) and decreased LA strain (LASr, LAScd, LASct) in HCM patients (P < 0.001).

Conclusions:

  • Three-dimensional transthoracic echocardiography (TTE) is a feasible method for assessing LA remodeling in HCM.
  • Patients with long-standing non-obstructive HCM exhibit adverse LA remodeling, characterized by impaired LA mechanics and increased septal thickness.
  • Diastolic dysfunction and reduced LA mechanics are more pronounced with increased septal thickness in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
8
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
2